Allegro MicroSystems(US:ALGM)2026-01-30 14:17Financial Performance - Net sales for the three-month period ended December 26, 2025, were $229.21 million, a 29% increase from $177.87 million for the same period in 2024[17] - Gross profit for the three-month period ended December 26, 2025, was $107.10 million, compared to $81.22 million for the same period in 2024, reflecting a gross margin improvement[17] - Operating income for the three-month period ended December 26, 2025, was $9.57 million, a significant recovery from an operating loss of $0.04 million in the same period last year[17] - Net income attributable to Allegro MicroSystems, Inc. for the three-month period ended December 26, 2025, was $8.30 million, compared to a net loss of $6.86 million for the same period in 2024[17] - Comprehensive income for the three-month period ended December 26, 2025, was $6.76 million, compared to a comprehensive loss of $14.36 million for the same period in 2024[19] - The net income for the period ending December 26, 2025, is $8,362,000, compared to a net loss of $6,799,000 for the previous period[21] - For the nine-month period ended December 26, 2025, net income was $1,783, compared to a net loss of $58,025 for the same period in 2024[26] - The company reported a basic net income per share of $0.04 for the three-month period ended December 26, 2025, compared to a loss of $0.04 per share in the same period last year[17] - The basic net income per share for the three-month period ended December 26, 2025, was $0.04, while the diluted net income per share was also $0.04[66] Assets and Liabilities - Total current assets increased to $515.41 million as of December 26, 2025, from $483.04 million as of March 28, 2025[15] - Total liabilities decreased to $458.30 million as of December 26, 2025, from $489.86 million as of March 28, 2025[15] - Total assets remained stable at $1.42 billion as of December 26, 2025, compared to $1.42 billion as of March 28, 2025[15] - The total equity at December 26, 2025, is $964,414,000, with a common stock amount of $1,852,000[21] - The company's total debt decreased to $287,714,000 as of December 26, 2025, from $346,126,000 on March 28, 2025, a reduction of 17%[59] - The fair value of the company's debt was $286,069,000 as of December 26, 2025, down from $343,275,000 on March 28, 2025, a decrease of 16.7%[50] Cash Flow and Investments - Net cash provided by operating activities for the nine-month period was $127,355, significantly up from $41,560 in the prior year[26] - The company reported a net cash used in investing activities of $21,160, a decrease from $34,245 in the prior year[26] - Cash and cash equivalents at the end of the period were $163,399, compared to $148,962 at the end of the previous year[26] Research and Development - Research and development expenses for the three-month period ended December 26, 2025, were $52.88 million, up from $43.32 million in the same period last year, indicating continued investment in innovation[17] Stock and Equity Transactions - The company issued 28,750,000 shares of common stock, raising $665,850,000 net of underwriting discounts[23] - The Company completed an Equity Offering of 28,750,000 shares at a public offering price of $24.00 per share, resulting in net proceeds of approximately $665.85 million after underwriting discounts[79] - The First Closing under the Share Repurchase Agreement involved repurchasing 28,750,000 shares for an aggregate consideration of $628.26 million, which was the Equity Offering price[80] - The Second Closing under the Share Repurchase Agreement involved repurchasing 10,017,315 shares for aggregate cash consideration of $225.55 million[81] - The Company repurchased common stock amounting to $(821,199,000)[23] Legal and Regulatory Matters - The Company is not aware of any pending or threatened legal proceedings that could have a material adverse effect on its business or financial condition[65] Restructuring and Charges - The restructuring plan initiated in January 2025 incurred costs of $754,000 and $2,328,000 for the three- and nine-month periods ended December 26, 2025, respectively, with cumulative costs reaching $8,088,000[75] - The Company incurred $3,132,000 and $6,278,000 of charges associated with additional restructuring activities during the three- and nine-month periods ended December 26, 2025, respectively[76] Market and Operational Risks - There have been no material changes in the Company's exposures to market risk since March 28, 2025[160]